Exact human lymphocyte antigen (HLA) allele matching and sequence vari
ation are important for matching organ donors, immune response studies
, and disease association investigations. The number of HLAs has reach
ed several hundred within each of the different classes. This level of
heterogeneity makes routine DNA typing to the allele level problemati
c using fixed probe and primer technologies. Routine large-batch scree
ning programs where only intermediate-level typing is required can be
performed in automated fashion by several DNA technologies. Screening
large numbers of samples with probe-based technologies, even oligo arr
ay chips, is cost effective. Allele-specific typing is most easily per
formed using direct sequencing. New sequencing technologies based on c
ycle sequencing and high-speed capillary gels have made routine sequen
cing for clinical typing a reality. The complexity of the class I locu
s requires a detailed analysis of all the polymorphisms within exons 2
and 3. Sequencing strategies are thus designed to use informative var
iable regions within the flanking introns and the flanking region as w
ell as the untranslated regions. Similar strategies are being adapted
to the complex class II DRB alleles, which now number about 200 differ
ent alleles. Greater understanding of HLA diversity and distribution t
hroughout humans and their relatives facilitates organ matching and th
e history and origins of human populations. Knowledge of parasites and
their role in the selection of alleles will ultimately lead to better
prediction and manipulation of the immune system response to these or
ganisms. HLA typing is used to determine relative risk to a variety of
autoimmune diseases. Future uses of molecular HLA typing may include
the prevention and cessation of these self-destructing diseases.